CYP3A
CYP3A is a subfamily of the cytochrome P450 superfamily of enzymes. These enzymes are involved in the metabolism of a variety of substances, including drugs and endogenous compounds. The CYP3A subfamily is one of the most important in human drug metabolism, responsible for the metabolism of approximately half of all marketed drugs.
Function[edit | edit source]
The CYP3A enzymes are primarily located in the liver and intestines, where they play a crucial role in the metabolism of drugs and other xenobiotics. They are also found in other tissues, including the kidney, lung, and brain. The enzymes function by oxidizing their substrates, which can lead to their activation, inactivation, or conversion to more easily excreted forms.
Subtypes[edit | edit source]
There are several subtypes of CYP3A enzymes, including CYP3A4, CYP3A5, CYP3A7, and CYP3A43. Of these, CYP3A4 is the most abundant and clinically important. It is responsible for the metabolism of a wide range of drugs, including statins, calcium channel blockers, and immunosuppressants.
Clinical significance[edit | edit source]
Due to their role in drug metabolism, variations in CYP3A activity can have significant clinical implications. For example, individuals with high CYP3A activity may metabolize drugs more quickly, potentially reducing their effectiveness. Conversely, those with low CYP3A activity may metabolize drugs more slowly, increasing the risk of adverse effects.
In addition, certain drugs and other substances can inhibit or induce CYP3A activity, potentially leading to drug-drug interactions. For example, grapefruit juice is a well-known inhibitor of CYP3A4, and can increase the blood levels of certain drugs.
Research[edit | edit source]
Research into CYP3A is ongoing, with a focus on understanding the factors that influence its activity and developing strategies to predict and manage drug-drug interactions. This includes the study of genetic variations that may affect CYP3A activity, as well as the development of new drugs that are less likely to be metabolized by CYP3A.
See also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
